195 related articles for article (PubMed ID: 31899315)
1. Modified Bu-zhong-yi-qi decoction synergies with 5 fluorouracile to inhibits gastric cancer progress via PD-1/PD- L1-dependent T cell immunization.
Xu R; Wu J; Zhang X; Zou X; Li C; Wang H; Yuan M; Chen M; Sun Q; Liu S
Pharmacol Res; 2020 Feb; 152():104623. PubMed ID: 31899315
[TBL] [Abstract][Full Text] [Related]
2. Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer.
Zhang Y; Wang F; Sun HR; Huang YK; Gao JP; Huang H
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2209-2222. PubMed ID: 33891173
[TBL] [Abstract][Full Text] [Related]
3. [Difference of gene expression profile in human gastric cancer grafted onto nude mice treated with WCA].
Zhao AG; Yang JK; You SF; Li T; Zhao HL; Gu Y; Tang LD
Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(19):2028-36. PubMed ID: 18161298
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of Bu-Zhong-Yi-Qi decoction, the water extract of Chinese traditional herbal medicine, on 5-fluorouracil-induced intestinal mucositis in mice.
Gou H; Gu LY; Shang BZ; Xiong Y; Wang C
Hum Exp Toxicol; 2016 Dec; 35(12):1243-1251. PubMed ID: 26801985
[TBL] [Abstract][Full Text] [Related]
5. Extract of
Cui XL; Li KJ; Ren HX; Zhang YJ; Liu XD; Bu BG; Wang L
World J Gastroenterol; 2019 Apr; 25(15):1854-1864. PubMed ID: 31057299
[TBL] [Abstract][Full Text] [Related]
6. [Effects of Bu Zhong Yi Qi decoction on CIH-induced interstitial lung fibrosis in mice].
Tang Y; Liu BB; Chen Q; Li TT; Ji ES; Li JR
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Sep; 38(5):559-563. PubMed ID: 37088770
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of Bu-zhong-yi-qi decoction, the water extract of Chinese traditional herbal medicine, on 5-fluorouracil-induced renal injury in mice.
Xiong Y; Shang B; Xu S; Zhao R; Gou H; Wang C
Ren Fail; 2016 Sep; 38(8):1240-8. PubMed ID: 27435211
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas.
Yang MW; Fu XL; Jiang YS; Chen XJ; Tao LY; Yang JY; Huo YM; Liu W; Zhang JF; Liu PF; Liu Q; Hua R; Zhang ZG; Sun YW; Liu DJ
World J Gastroenterol; 2019 Apr; 25(14):1684-1696. PubMed ID: 31011254
[TBL] [Abstract][Full Text] [Related]
9. Repeated cycles of 5-fluorouracil chemotherapy impaired anti-tumor functions of cytotoxic T cells in a CT26 tumor-bearing mouse model.
Wu Y; Deng Z; Wang H; Ma W; Zhou C; Zhang S
BMC Immunol; 2016 Sep; 17(1):29. PubMed ID: 27645787
[TBL] [Abstract][Full Text] [Related]
10. Immunochemotherapy benefits in gastric cancer patients stratified by programmed death-1 ligand-1.
Hsu JT; Hsu CS; Le PH; Chen TC; Chou WC; Lin CY; Yeh TS
J Surg Res; 2017 May; 211():30-38. PubMed ID: 28501128
[TBL] [Abstract][Full Text] [Related]
11. 5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers.
Van Der Kraak L; Goel G; Ramanan K; Kaltenmeier C; Zhang L; Normolle DP; Freeman GJ; Tang D; Nason KS; Davison JM; Luketich JD; Dhupar R; Lotze MT
J Immunother Cancer; 2016; 4():65. PubMed ID: 27777774
[TBL] [Abstract][Full Text] [Related]
12. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
[TBL] [Abstract][Full Text] [Related]
13. Fatty Acid Oxidation Controls CD8
Lin R; Zhang H; Yuan Y; He Q; Zhou J; Li S; Sun Y; Li DY; Qiu HB; Wang W; Zhuang Z; Chen B; Huang Y; Liu C; Wang Y; Cai S; Ke Z; He W
Cancer Immunol Res; 2020 Apr; 8(4):479-492. PubMed ID: 32075801
[TBL] [Abstract][Full Text] [Related]
14. Bu-zhong-yi-qi pill alleviate the chemotherapy-related fatigue in 4 T1 murine breast cancer model.
Ouyang M; Liu Y; Tan W; Xiao Y; Yu K; Sun X; Huang Y; Cheng J; Luo R; Zhao X
BMC Complement Altern Med; 2014 Dec; 14():497. PubMed ID: 25511260
[TBL] [Abstract][Full Text] [Related]
15. [Effect of cisplatin alone or combined with monoclonal anti-programmed death ligand-1 antibody on lung adenocarcinoma cell line SPCA-1 and T lymphocytes].
Pan X; Xing Y; Shi M; Zhou T; Qian B; Chen Y
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jun; 37(6):416-20. PubMed ID: 25200040
[TBL] [Abstract][Full Text] [Related]
16. MiR-21 Participates in the PD-1/PD-L1 Pathway-Mediated Imbalance of Th17/Treg Cells in Patients After Gastric Cancer Resection.
Zheng X; Dong L; Wang K; Zou H; Zhao S; Wang Y; Wang G
Ann Surg Oncol; 2019 Mar; 26(3):884-893. PubMed ID: 30565043
[TBL] [Abstract][Full Text] [Related]
17. PD-1 and PD-L1 Up-regulation Promotes T-cell Apoptosis in Gastric Adenocarcinoma.
Chiu YM; Tsai CL; Kao JT; Hsieh CT; Shieh DC; Lee YJ; Tsay GJ; Cheng KS; Wu YY
Anticancer Res; 2018 Apr; 38(4):2069-2078. PubMed ID: 29599324
[TBL] [Abstract][Full Text] [Related]
18. A screening strategy for bioactive components of Bu-Zhong-Yi-Qi-Tang regulating spleen-qi deficiency based on "endobiotics-targets-xenobiotics" association network.
Hu L; Chen J; Duan H; Zou Z; Qiu Y; Du J; Chen J; Yao X; Kiyohara H; Nagai T; Yao Z
J Ethnopharmacol; 2023 Oct; 314():116605. PubMed ID: 37178982
[TBL] [Abstract][Full Text] [Related]
19. MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells.
Zheng Z; Sun R; Zhao HJ; Fu D; Zhong HJ; Weng XQ; Qu B; Zhao Y; Wang L; Zhao WL
Mol Cancer; 2019 Mar; 18(1):54. PubMed ID: 30925928
[TBL] [Abstract][Full Text] [Related]
20. The clinical application and pharmacological mechanism of Bu-Zhong-Yi-Qi decoction for treating cancer-related fatigue: An overview.
Li G; Ding J; Zhang Y; Wang X
Biomed Pharmacother; 2022 Dec; 156():113969. PubMed ID: 36411646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
